Virtual physiological human research initiative: The future for rational HIV treatment design?

Future HIV Therapy

Volumn 2, Issue 5, 2008, Pages 419-425

  Stoica, Ileana ^a   Sadiq, S Kashif ^a   Gale, Catherine V ^a   Coveney, Peter V ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Decision support; Drug design; Drug resistance; HIV; Modeling; Molecular dynamics; Prediction; Protease

Indexed keywords

RALTEGRAVIR; SAQUINAVIR;

ANTIVIRAL RESISTANCE; ARTICLE; AUTOMATION; BINDING AFFINITY; CLINICAL PRACTICE; COMPUTER MODEL; DECISION MAKING; DECISION SUPPORT SYSTEM; DRUG BINDING; DRUG EFFICACY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATHEMATICAL ANALYSIS; MEDICAL RESEARCH; METHODOLOGY; MOLECULAR MODEL; NONHUMAN; PATIENT CARE; TREATMENT PLANNING;

EID: 55349084374     PISSN: 17469600     EISSN: None     Source Type: Journal    
DOI: 10.2217/17469600.2.5.419     Document Type: Article

References (19)

1. Alfano M, Poli G: The HIV lifecycle: multiple targets for antiretroviral agents. Drug Rev. Online 1, 83-92 (2004).
2. Sloot PMA, Boukhanovsky AV, Keulen W, Tirado-Ramos A, Boucher CA: A grid-based HIV expert system. J. Clin. Monit. Comput. 19, 4-5 (2005).
3. Stoica I, Sadiq SK, Coveney PV: Rapid and accurate prediction of binding free energies for saquinavir-bound HIV-1 proteases. J. Am. Chem. Soc. 130, 2639-2348 (2008).
4. Maschera B, Darby G, Palu G et al.: Human immunodeficiency virus: mutations in the viral protease that confer resistance to saquinavir increase the dissociation rate constant of the protease-saquinavir complex. J. Biol. Chem. 271, 33231-33235 (1996).
5. Sadiq SK, Wright D, Watson SJ, Zasada SJ, Stoica I, Coveney PV: Automated molecular simulation-based binding affinity calculator for ligand-bound HIV-1 proteases. J. Chem. Inf. Model. (2008) (Epub ahead of print).
6. Coveney PV, Saksena RS, Zasada SJ, McKeown M, Pickles S: The application hosting environment: lightweight middleware for grid-based computational science. Comput. Phys. Commun. 176, 406-418 (2007).
7. Beckman P, Beschastnikh I, Nadella S, Trebon N: Building an infrastructure for urgent computing. In: High Performance Computing and Grids in Action. IOS Press, Amsterdam, Holland (2007).
8. Vercauteren J, Vandamme AM: Algorithms for the interpretation of HIV-1 genotypic drug resistance information. Antiviral Res. 71, 335-342 (2006).
9. Shenderovich MD, Kagan RM, Heseltine PNR, Ramnarayan K: Structure-based phenotyping predicts HIV-1 protease inhibitor resistance. Prot. Sci. 12, 1706-1718 (2003).
10. Cao ZM, Han LY, Zheng CJ et al.: Computer prediction of drug resistance mutations in proteins, Drug Discov. Today 10, 521-525 (2005).
11. Jenwitheesuk E, Samudrala R: Prediction of HIV-1 protease inhibitor resistance using a protein-inhibitor flexible docking approach, Antivir. Ther. 10, 157-166 (2005).
12. Perryman AL, Lin JH, McCammon JA: Optimization and computational evaluation of a series of potential active site inhibitors of the V82F/ I84V drug-resistant mutant of HIV-1 protease: an application of the relaxed complex method of structure-based drug design. Chem. Biol. Drug Des. 67, 336-345 (2006).
13. Thorsteinsdottir HB, Schwede T, Zoete V, Meuwly M: How inaccuracies in protein structure models affect estimates, of protein-ligand interactions: computational analysts of HIV-1 protease inhibitor binding. Proteins 65, 407-423 (2006).
14. Lengauer T, Sing T: Bioinformatics-assisted anti-HIV therapy. Nat. Rev. Microbiol. 4, 790-797 (2006).
15. Wang J, Kang X, Kuntz ID, Kollman PA: Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA. J. Med. Chem. 48, 2432-2444 (2005).
16. Evering TH, Markovitz M: Raltegravir: an integrase inhibitor for HIV-1. Expert Opin. Investig. Drugs 17, 413-432 (2008).
17. Strockbine B, Rizzo RC: Binding of antifusion peptides with HIVgp41 from molecular dynamics simulations: quantitative correlation with experiment. Proteins 67, 630-642 (2007).
18. Herschhorn A, Oz-Gleenberg I, Hizi A: Quantitative analysis of the interactions between HIV-1 integrase and retroviral reverse transcriptases. Biochem. J. 412, 163-170 (2008).
19. Sakiq SK, Mazzeo MD, Zasada SJ et al.: Patient-specific simulation as a basis for clinical decision-making. Philos. Trans. R. Soc. A. DOI: 10.1098/rsta.2008.0100 (2008) (Epub ahead of print).